Warfarin use and fracture risk - PubMed

Review

Warfarin use and fracture risk

S L Booth et al. Nutr Rev. 2000 Jan.

Abstract

Two recent studies examined the association between chronic use of warfarin, a vitamin K antagonist, and fracture rate among older women. Whereas one study reported no association, the other reported a significantly higher risk for vertebral and rib fractures among warfarin users compared with nonusers. The effect of vitamin K antagonists on age-related bone loss continues to be controversial.

Similar articles

• Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group.

  Jamal SA, Browner WS, Bauer DC, Cummings SR. Jamal SA, et al. Ann Intern Med. 1998 May 15;128(10):829-32. doi: 10.7326/0003-4819-128-10-199805150-00006. Ann Intern Med. 1998. PMID: 9599195

• Blood thinner may affect bone strength.

  [No authors listed] [No authors listed] Health News. 2006 May;12(5):8. Health News. 2006. PMID: 16685750 No abstract available.

• Long-term use of oral anticoagulants and the risk of fracture.

  Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O'Fallon WM, Castro MR, Melton LJ 3rd. Caraballo PJ, et al. Arch Intern Med. 1999 Aug 9-23;159(15):1750-6. doi: 10.1001/archinte.159.15.1750. Arch Intern Med. 1999. PMID: 10448778

• Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.

  Turagam MK, Velagapudi P, Flaker GC. Turagam MK, et al. Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Clin Interv Aging. 2015. PMID: 26366064 Free PMC article. Review.

• Vitamin K to prevent fractures in older women: systematic review and economic evaluation.

  Stevenson M, Lloyd-Jones M, Papaioannou D. Stevenson M, et al. Health Technol Assess. 2009 Sep;13(45):iii-xi, 1-134. doi: 10.3310/hta13450. Health Technol Assess. 2009. PMID: 19818211 Review.

Cited by

• Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.

  Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, Mizuno K, Varnum B, Fukatsu A, Doi T, Kita T. Yanagita M, et al. Am J Pathol. 2001 Apr;158(4):1423-32. doi: 10.1016/S0002-9440(10)64093-X. Am J Pathol. 2001. PMID: 11290560 Free PMC article.

• Evaluation of surgical outcomes in elderly patients with rib fractures: A single-centre propensity score matching study.

  Zhang D, Jiao C, Xi S, Wang L, Li R, Zhang Q. Zhang D, et al. Front Surg. 2023 Apr 18;10:1174365. doi: 10.3389/fsurg.2023.1174365. eCollection 2023. Front Surg. 2023. PMID: 37143770 Free PMC article.

• [Oral anticoagulation using coumarins - an update].

  Sucker C, Litmathe J. Sucker C, et al. Wien Med Wochenschr. 2018 Apr;168(5-6):121-132. doi: 10.1007/s10354-017-0577-z. Epub 2017 Jun 12. Wien Med Wochenschr. 2018. PMID: 28608277 Review. German.

• Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

  Norby FL, Bengtson LGS, Lutsey PL, Chen LY, MacLehose RF, Chamberlain AM, Rapson I, Alonso A. Norby FL, et al. BMC Cardiovasc Disord. 2017 Sep 6;17(1):238. doi: 10.1186/s12872-017-0672-5. BMC Cardiovasc Disord. 2017. PMID: 28874129 Free PMC article.

• Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.

  Fusaro M, Crepaldi G, Maggi S, Galli F, D'Angelo A, Calò L, Giannini S, Miozzo D, Gallieni M. Fusaro M, et al. J Endocrinol Invest. 2011 Apr;34(4):317-23. doi: 10.1007/BF03347093. Epub 2010 Nov 16. J Endocrinol Invest. 2011. PMID: 21088475 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information